Biotech for less than a buck. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than a buck.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RWReeves who wrote (543)	7/10/2000 5:16:13 PM
From: nigel bates	Read Replies (1) of 743

(Still holding my VVUS too...) biz.yahoo.com LEXINGTON, Mass., July 10 /PRNewswire/ -- MacroChem Corporation (Nasdaq: MCHM - news) announced today it will begin a pivotal Phase 3 clinical trial of its investigational topical impotence drug, Topiglan(TM), following favorable U.S. Food & Drug Administration review of its proposed trial protocol. This pivotal Phase 3 trial is the first pivotal trial of a topical ED therapy to be initiated in the U.S.* (Photo: newscom.com Don't bother, the photo isn't what you might expect (g). nig

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next